Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
Clinical trial NCT04433442 · COMPLETED
Trial details
- NCT number
- NCT04433442
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-04
- Primary completion
- 2025-06-13
- Enrollment
- 2324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.